News & Analysis Latest News & Analysis
EP Vantage Drug Approvals Filings R&D Deals Patents  
Calendar of Events Latest Events
Overview Financial Results Conferences Approvals (PDUFA)  

Calendar of Events

EvaluatePharma®’s Calendar of Events is the first fully comprehensive online service to track events impacting shareholder value, including:

  • PDUFA data
  • Filings and approvals
  • Clinical trial initiation and results
  • Patent expiries and generic launches

Contact us to find out more

Read more about our Calendar of Events

About EvaluatePharma®

Our expertise is trusted and relied upon by the top global pharma and biotech companies, the investment community and leading consultancies - Request a Free Trial to find out why.

How to access FREE content

  • Search the content using the search box at the top of every page
  • Browse content by Company, Product, Generic Name, Therapeutic Category or Indication using "Browse By" link from the navigation bar
  • Create Peer Groups to compare Companies using "Peer Groups" link from the navigation bar

Download our brochure to discover Analysis & Insight Exclusive to EvaluatePharma

From Business Development & Licensing to Investment Banking see our range of Solutions.

Request a Free Trial to access our full service

Welcome to EvaluatePharma®

The premier source for pharma and biotech analysis delivering exclusive, trusted commercial insight into industry performance for over 10 years.

NEW: World Preview 2014 - download report

The Queen's Awards for Enterprise: International Trade 2009


WINNER OF QUEEN'S AWARD
FOR ENTERPRISE: INTERNATIONAL
TRADE 2009

Read more


You are currently a Guest User – giving you FREE access to a selection of historical analyses and insights from EvaluatePharma®.

Options:

  1. Access FREE content as a Guest User
  2. Register Now for FREE to access more content including 2008 Product Sales and Rankings
  3. Request a Free Trial for full access to EvaluatePharma or Subscribe Now

Find out why so many corporations rely on Our Products, including EvaluatePharma Alpha, to shape their view of the future performance of their industry.

Company & Product Rankings Commercial rankings - leading products and companies
MS: Top 5 Products 2010 Diabetes: Top 5 Companies 2010  

     Note:  Worldwide market share for Multiple Sclerosis products in 2010, based on company
     consolidated sales.
     Source: EvaluatePharma® consensus forecasts

Deals Licensing and M&A
Latest M&A Licensing: Top 10 2008 News  
Deal Announcement DateDeal Announcement Date Target Company or Business Unit Deal Value ($m) Acquiring Company M&A Deal Status
2/1/2010 Mepha Group 590 Cephalon Open
1/28/2010 Eden Biodesign 15 Watson Pharmaceuticals Closed
1/12/2010 TOPIGEN Pharmaceuticals 20 Pharmaxis Open
1/11/2010 Humalys 38 Vivalis Open
1/8/2010 CPEX Pharmaceuticals 31 Consortium of Investors Open
1/6/2010 PharmaForce - Daiichi Sankyo Closed
1/4/2010 Alcon 38,637 Novartis Open
1/4/2010 BioForm Medical 253 Merz Open
12/31/2009 Simayla Pharmaceuticals - Zydus Cadila Closed
12/30/2009 Fidia Advanced Biopolymers 17 Anika Therapeutics Closed